Life Science

We work at the intersection of physics, engineering and the biological sciences, creating and developing new technology for the life science industry.

Life Science Update

Life science research is growing at an unprecedented rate. The advent of DNA sequencing and editing has created new fields of research, commercial products and applications. Progress in cell therapy and personalised medicine is driving the need for new approaches to research and manufacturing. The output of modern biolabs is scaling rapidly as manual processes give way to workflow automation. Synthetic biology has also emerged as a new field with great potential, driving the need for new molecular design tools and synthesis approaches. Our team works in these and other emerging application areas, inventing, developing and implementing effective commercial solutions.  

What we do

Building on a long track record in life science instrumentation, we routinely design systems capable of meeting demanding biological and physical hardware requirements. Understanding the interplay between the fundamental biology of a process and the physical behaviour of a system is critical to successful development. Recognising this, we have built a tightly integrated team of biologists, physicists and engineers capable of optimising solutions with a very high degree of multi-disciplinary design complexity.  

We have extensive labs and fabrication facilities, including a bio-MEMS lab. This allows us to rapidly prototype, iterate and validate the biological and physical aspects of system design. Beyond prototyping we have the capacity to scale to pre-production and transfer to manufacture.

TTP has also established an advanced molecular design capability, taking engineering to the molecular level with a view to achieving improved molecular or cellular recognition, reaction mechanisms and detection chemistries. We develop cutting-edge methodologies for diagnostic systems and can rapidly develop novel biomarker detection scaffolds for improved diagnostics, immunoassays and research tools. 

Explore More industries

Drug Delivery

Pharmaceutical companies face substantial challenges, from constraints in health spending to weakening drug pipelines. Yet opportunities exist for those bold enough to adapt, ranging from connected devices that drive adherence to generic devices at cost points previously thought impossible.

Medical Devices

Disruptive change is rolling through the medical device industry as value-based healthcare and digitisation spread from niches to the mainstream. This is a challenging time, but it presents real opportunities for those ambitious companies prepared to reinvent themselves.

In-vitro Diagnostics

The diagnostic market is at a moment of change. New approaches, such as sequencing, are gaining traction; companion diagnostics are driving closer integration with therapy; continuous monitoring is enabling new diagnostic information; and market drivers are demanding low cost distribution of clinical quality data.


Human therapies are adapting to tackle increasingly complex immunological diseases and conditions. These therapies often rely on tightly controlled cell cultures in order to produce therapeutic drugs efficiently, such as monoclonal antibodies or culture of the patient’s own genetically-engineered cells, as part of an autologous cell therapy workflow.


Emerging biosensor technologies are enabling the measurement and analysis of valuable trace markers, leading to improved clinical outcomes by allowing the accurate observation of previously undetectable physiological signals.

Smart Implants

Increasing numbers of people are suffering from chronic conditions. Through the creation of tiny, fully integrated real-time measurement systems, smart implants are bringing the benefits of laboratory-grade telemetry to their lives.

Digital Health

As with other industries, digital technology is touching every aspect of healthcare. But health is unique in its complexity, and innovation requires deep insight.

Medical Imaging

Medical imaging is required to meet the needs of advanced diagnostics and the demands of emerging markets, presenting the sector with sizeable rewards for innovation.


Surgery is a fertile area for medical device innovation with remarkable developments occurring in minimally invasive and robotic assisted techniques. The future of the operating room relies on intraoperative technologies which improve clinical and economic values as measured by procedure outcome, workflow efficiency and patient safety.

Get in touch

We use cookies to improve your experience on our site. To find out more, read our updated privacy policy. More information.